NASDAQ · ELAN
Healthcare · Drug Manufacturers - Specialty & Generic
$23.00
Down-$0.13 (-0.57%)
Updated Sep 16, 2026, 8:02 PM
SID Score
5.2/10
Composite research score
Smart Money
54/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
ELAN closed at $23.00 after 20 trading sessions, down 2.71% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $23.16 | $23.47 | $22.65 | $23.00 | 8.42M |
| Sep 14, 2026 | $23.50 | $23.52 | $23.02 | $23.15 | 3.88M |
| Sep 11, 2026 | $23.20 | $23.32 | $22.65 | $23.17 | 4.74M |
| Sep 10, 2026 | $23.37 | $23.61 | $22.86 | $22.86 | 5.63M |
| Sep 9, 2026 | $23.91 | $23.96 | $23.495 | $23.55 | 3.88M |
| Sep 8, 2026 | $24.37 | $24.38 | $23.87 | $23.97 | 3.91M |
| Sep 4, 2026 | $24.20 | $24.71 | $24.00 | $24.50 | 3.72M |
| Sep 3, 2026 | $24.94 | $25.065 | $23.74 | $24.42 | 5.92M |
| Sep 2, 2026 | $23.97 | $24.92 | $23.87 | $24.68 | 6.74M |
| Sep 1, 2026 | $24.04 | $24.395 | $23.90 | $23.91 | 3.95M |
| Aug 31, 2026 | $23.97 | $24.015 | $23.41 | $23.92 | 5.36M |
| Aug 28, 2026 | $24.45 | $24.755 | $23.99 | $24.11 | 4.17M |
| Aug 27, 2026 | $24.91 | $25.04 | $24.42 | $24.49 | 4.09M |
| Aug 26, 2026 | $25.02 | $25.19 | $24.84 | $25.08 | 4.15M |
| Aug 25, 2026 | $24.60 | $25.405 | $24.46 | $25.09 | 5.31M |
| Aug 24, 2026 | $24.11 | $24.54 | $24.03 | $24.42 | 3.95M |
| Aug 21, 2026 | $23.91 | $24.15 | $23.685 | $23.97 | 4.76M |
| Aug 20, 2026 | $24.21 | $24.37 | $23.38 | $23.56 | 4.94M |
| Aug 19, 2026 | $24.08 | $24.57 | $24.00 | $24.50 | 3.97M |
| Aug 18, 2026 | $23.59 | $23.85 | $23.44 | $23.64 | 5.08M |
The latest Smart Investors Daily articles mentioning ELAN.
ELAN research
Company profile and research snapshot.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 6, 2026 | Keybanc | Overweight | — |
| Aug 6, 2026 | UBS | Buy | — |
| Jul 22, 2026 | Morgan Stanley | Equal-Weight | — |
| Jun 18, 2026 | TD Cowen | Buy | — |
| May 7, 2026 | Citigroup | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 11, 2026
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.
Yahoo · Sep 10, 2026
Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. Jeff Simmons, president and CEO, Bob VanHimbergen, executive vice president and CFO, and Bobby Modi, executive vice president U.S. Pet Health and Global Digital Transformation will participate in a fireside chat on Tuesday, September 15 at 2:35 p.m. ET.
Yahoo · Sep 4, 2026
Purchasing 40,000 shares is a bullish signal for shareholders.
Yahoo · Aug 31, 2026
The completed 25,000-square-foot Elwood site expansion bolsters 's monoclonal antibody (mAb) production; supports delivery of next-generation pipelineINDIANAPOLIS, IN / ACCESS Newswire / August 31, 2026 / Animal Health Incorporated (NYSE:ELAN) announced the on-time completion of a 25,000-square-foot manufacturing expansion of its Elwood, Kansas manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens 's leadership in
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ELAN.
